Ubs Oconnor LLC Ionis Pharmaceuticals Inc Transaction History

Ubs Oconnor LLC

$1.51 Billion
Q4 2024

A detailed history of Ubs Oconnor LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 60,580 shares of IONS stock, worth $1.72 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

60,580

Holding current value

$1.72 Million

% of portfolio

0.14%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$33.73 - $40.36 $796,803 - $953,424	23,623 Added 63.92%	60,580 $2.12 Million
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $225,858 - $292,386	-5,638 Reduced 13.24%	36,957 $1.48 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $6,670 - $8,729	183 Added 0.43%	42,595 $2.03 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $579,509 - $738,347	13,788 Added 48.17%	42,412 $1.84 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $1.45 Million - $1.73 Million	-33,435 Reduced 53.88%	28,624 $1.45 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $385,000 - $471,300	-10,000 Reduced 13.88%	62,059 $2.81 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $2.5 Million - $3.12 Million	72,059 New	72,059 $2.96 Billion
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $977,816 - $1.2 Million	29,119 Added 37.16%	107,489 $3.84 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $886,165 - $1.11 Million	23,873 Added 43.81%	78,370 $0
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $255,780 - $340,620	-7,000 Reduced 11.38%	54,497 $2.41 Billion
Q2 2022 Aug 12, 2022	BUY	$31.71 - $43.0 $1.34 Million - $1.82 Million	42,297 Added 220.3%	61,497 $2.28 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $1.15 Million - $1.42 Million	-38,436 Reduced 66.69%	19,200 $711,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $3.1 Million - $3.76 Million	57,636 New	57,636 $3.48 Million

Others Institutions Holding IONS

# of Institutions

408

Shares Held

131M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.03B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account